UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000002861
Receipt number R000003492
Scientific Title A phase II study of erlotinib for patients with pretreated non-small cell lung cancer with brain metastasis and sensitive EGFR mutations.
Date of disclosure of the study information 2009/12/08
Last modified on 2013/01/30 13:34:18

No. Disposal Last modified on Item of update
1 Insert 2009/12/08 19:12:46
2 Update 2013/01/30 13:34:18 Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Results